What are terpenes, and do they change how treatment works?
Terpenes are the most heavily marketed idea in this field and one of the least settled. They are real compounds with real properties. Whether they meaningfully change what a medicine does in a human being is a different question, and a much more open one.
The short answer
- Terpenes are aromatic compounds found across the plant kingdom, not unique to cannabis.
- They are why different plants smell different — including cannabis.
- Most evidence is laboratory or animal work, often at concentrations far above those inhaled or swallowed.
- No terpene is licensed as a medicine in the UK for any indication.
- Claims that a specific terpene treats a specific symptom are not supported by controlled human trials.
What terpenes are
Terpenes are volatile aromatic compounds produced by many plants. They are what gives pine its resinous smell, citrus peel its sharpness and lavender its scent. Cannabis produces a wide range of them, which is why different plants smell distinctly different from one another.
In the plant they mostly serve ecological purposes — deterring herbivores, attracting pollinators, responding to stress. Their presence in a medicine is a consequence of extracting from a plant rather than a designed feature.
Some of the same terpenes appear in the herbs and spices in an ordinary kitchen, in quantities not far off those present in a medicinal product. That is a useful reference point when reading claims about their potency.
What the evidence actually shows
The great majority of terpene research is preclinical: isolated cells, or animal models, frequently using concentrations far higher than a person would ever be exposed to from a medicine.
There is a reasonable body of laboratory work suggesting that individual terpenes have anti-inflammatory, analgesic or sedative properties in those settings. There is very little controlled human evidence that these effects survive at realistic exposures, and essentially none showing that varying the terpene content of a cannabis-based medicine changes clinical outcomes in patients.
How to read a terpene claim
Three questions usually settle it. Was the study done in humans? Were the concentrations comparable to those in a medicine taken by a patient? Was there a control group?
A great deal of terpene marketing rests on studies that fail all three.
None of this means terpenes are irrelevant. It means the honest position is uncertainty, and that a clinic presenting terpene profiles as a basis for choosing treatment is going beyond what the evidence supports.
What this means in practice
For a patient, the practical significance of terpenes is smaller than the volume of content about them suggests.
The decisions that matter clinically are which cannabinoids, in what balance, by what route, at what dose, reviewed how often. Those are the levers a specialist actually adjusts, and they are covered in How is a dose decided and adjusted?
If you notice that one product suits you better than another, that is worth reporting to your prescriber — it is real information about you. Attributing it to a particular terpene is a further step that the evidence does not currently support.
Frequently asked questions
What are terpenes?
Aromatic compounds produced by many plants, responsible for their characteristic smells. Cannabis produces a wide range of them, which is why different plants smell different. They are not unique to cannabis and appear in many common herbs and foods.
Do terpenes change the effects of medical cannabis?
It is not established that they do at the exposures involved in a medicine. Most terpene research is laboratory or animal work at concentrations far above realistic human exposure, and there is essentially no controlled evidence that varying terpene content changes clinical outcomes.
Is there a best terpene for pain or sleep?
No controlled human trial supports choosing treatment on that basis. Claims that a specific terpene treats a specific symptom go beyond the evidence.
Why do clinics talk about them so much?
They are a way to differentiate products in a market where advertising the medicines themselves is not permitted. That is a commercial reason rather than a clinical one.
Sources and further reading
Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.
- National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (2017)
- NICE guideline NG144: Cannabis-based medicinal products
- NHS: Medical cannabis (and cannabis oils)
- MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use